» Articles » PMID: 33751965

Influence of Cholesterol on Cancer Progression and Therapy

Overview
Journal Transl Oncol
Specialty Oncology
Date 2021 Mar 22
PMID 33751965
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesterol is a fundamental molecule necessary for the maintenance of cell structure and is vital to various normal biological functions. It is a key factor in lifestyle-related diseases including obesity, diabetes, cardiovascular disease, and cancer. Owing to its altered serum chemistry status under pathological states, it is now being investigated to unravel the mechanism by which it triggers various health complications. Numerous clinical studies in cancer patients indicate an alteration in blood cholesterol level (either decreased or increased) in comparison to normal healthy individuals. This article elaborates on our understanding as to how cholesterol is being hijacked in the malignancy for the development, survival, stemness, progression, and metastasis of cancerous cells. Also, it provides a glimpse of how cholesterol derived entities, alters the signaling pathway towards their advantage. Moreover, deregulation of the cholesterol metabolism pathway has been often reported to hamper various treatment strategies in different cancer. In this context, attempts have been made to bring forth its relevance in being targeted, in pre-clinical and clinical studies for various treatment modalities. Thus, understanding the role of cholesterol and deciphering associated molecular mechanisms in cancer progression and therapy are of relevance towards improvement in the management of various cancers.

Citing Articles

Xanthohumol Sensitizes Melanoma Cells to Vemurafenib by Lowering Membrane Cholesterol and Increasing Membrane Fluidity.

Devinat M, Thevenard-Devy J, Ghilane F, Devy J, Chazee L, Terryn C Int J Mol Sci. 2025; 26(5).

PMID: 40076912 PMC: 11901044. DOI: 10.3390/ijms26052290.


Colorectal Cancer: Pathogenesis and Targeted Therapy.

Li J, Pan J, Wang L, Ji G, Dang Y MedComm (2020). 2025; 6(3):e70127.

PMID: 40060193 PMC: 11885891. DOI: 10.1002/mco2.70127.


Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z Mol Cancer. 2025; 24(1):61.

PMID: 40025508 PMC: 11874147. DOI: 10.1186/s12943-025-02258-1.


Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.

Scalambra L, Ruzzi F, Pittino O, Semprini M, Cappello C, Angelicola S J Transl Med. 2025; 23(1):136.

PMID: 39885551 PMC: 11784117. DOI: 10.1186/s12967-025-06126-w.


Cholesterol deficiency directs autophagy-dependent secretion of extracellular vesicles.

Yaeger J, Sengupta S, Walz A, Morita M, Morgan T, Vermeer P bioRxiv. 2025; .

PMID: 39829772 PMC: 11741461. DOI: 10.1101/2025.01.11.632510.